Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
Development and Management of Registry in Patients With Gynecologic Cancer in Korea
- Status
- RECRUITING
- Phase
- N/A
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- Status
- RECRUITING
- Phase
- PHASE2
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study of AVZO-021 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- NA
A Study of CDX-585 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
- Status
- RECRUITING
- Phase
- N/A
A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1